Servicer Evaluation: Bayview Loan Servicing LLC Nov 11

  • ID: 2039281
  • November 2011
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services maintains a STRONG ranking on Bayview Loan Servicing LLC (BLS), a wholly owned subsidiary of Bayview Asset Management LLC (BAM), as a residential special mortgage loan servicer. Standard & Poor's based the ranking on its view that BLS demonstrates a solid level (per our criteria) of competence and efficiency and effectiveness in managing its servicing portfolio. The company, in our opinion, maintains an experienced and tenured management team, solid automation, sound policies and procedures, established and unwavering internal controls, and a demonstrated expertise in default and asset management. BLS continues to manage the growth of its servicing portfolio, which has steadily increased over the past several years to more than 35,000 loans with an aggregate...

Companies mentioned in this report are: Bayview Loan Servicing LLC
Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Bayview Loan Servicing LLC

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.